| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1080 | 2021 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 823 | 2022 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 431 | 2021 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 357 | 2021 |
| Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant P Elliott, D Haw, H Wang, O Eales, CE Walters, KEC Ainslie, C Atchison, ... Science 374 (6574), eabl9551, 2021 | 120 | 2021 |
| Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland A da Silva Filipe, JG Shepherd, T Williams, J Hughes, E Aranday-Cortes, ... Nature Microbiology 6 (1), 112-122, 2021 | 102 | 2021 |
| Transcriptional profiling of disease-induced host responses in bovine tuberculosis and the identification of potential diagnostic biomarkers E Aranday-Cortes, PJ Hogarth, DA Kaveh, AO Whelan, ... PloS one 7 (2), e30626, 2012 | 78 | 2012 |
| Upregulation of IL‐17A, CXCL9 and CXCL10 in Early‐Stage Granulomas Induced by Mycobacterium bovis in Cattle E Aranday‐Cortes, NC Bull, B Villarreal‐Ramos, J Gough, D Hicks, ... Transboundary and emerging diseases 60 (6), 525-537, 2013 | 72 | 2013 |
| Global gene transcriptome analysis in vaccinated cattle revealed a dominant role of IL-22 for protection against bovine tuberculosis S Bhuju, E Aranday-Cortes, B Villarreal-Ramos, Z Xing, M Singh, ... PLoS pathogens 8 (12), e1003077, 2012 | 70 | 2012 |
| Mycobacterium bovis-BCG Vaccination Induces Specific Pulmonary Transcriptome Biosignatures in Mice E Aranday Cortes, D Kaveh, J Nunez-Garcia, PJ Hogarth, ... PLoS One 5 (6), e11319, 2010 | 53 | 2010 |
| Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data MD Parker, BB Lindsey, S Leary, S Gaudieri, A Chopra, M Wyles, ... Genome research 31 (4), 645-658, 2021 | 48 | 2021 |
| Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries A da Silva Filipe, V Sreenu, J Hughes, E Aranday-Cortes, WL Irving, ... Journal of hepatology 67 (6), 1348-1350, 2017 | 37 | 2017 |
| Interferon lambda 4 impacts the genetic diversity of hepatitis C virus MA Ansari, E Aranday-Cortes, CLC Ip, A da Silva Filipe, SH Lau, ... Elife 8, e42463, 2019 | 33 | 2019 |
| Alternative activation modifies macrophage resistance to Mycobacterium bovis U Castillo-Velázquez, E Aranday-Cortés, JA Gutiérrez-Pabello Veterinary microbiology 151 (1-2), 51-59, 2011 | 33 | 2011 |
| A polymorphic residue that attenuates the antiviral potential of interferon lambda 4 in hominid lineages CGG Bamford, E Aranday-Cortes, IC Filipe, S Sukumar, D Mair, AS Filipe, ... PLoS Pathogens 14 (10), e1007307, 2018 | 31 | 2018 |
| Amino acid substitutions in genotype 3a hepatitis C virus polymerase protein affect responses to sofosbuvir PAC Wing, M Jones, M Cheung, S DaSilva, C Bamford, WYJ Lee, ... Gastroenterology 157 (3), 692-704. e9, 2019 | 30 | 2019 |
| Interpreting viral deep sequencing data with GLUE JB Singer, EC Thomson, J Hughes, E Aranday-Cortes, J McLauchlan, ... Viruses 11 (4), 323, 2019 | 28 | 2019 |
| Genomic epidemiology of SARS-CoV-2 spread in Scotland highlights the role of European travel in COVID-19 emergence ADS Filipe, J Shepherd, T Williams, J Hughes, E Aranday-Cortes, ... MedRxiv, 2020.06. 08.20124834, 2020 | 27 | 2020 |
| Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission LB Snell, CL Fisher, U Taj, O Stirrup, B Merrick, A Alcolea-Medina, ... Clinical Microbiology and Infection 28 (1), 93-100, 2022 | 26 | 2022 |
| Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy DA Smith, D Bradshaw, JL Mbisa, CF Manso, DF Bibby, JB Singer, ... Journal of Viral Hepatitis 28 (9), 1256-1264, 2021 | 24 | 2021 |
